Sanofi backs Anap­tys­Bio’s $100M of­fer­ing, help­ing cat­a­pult the biotech’s stock

Anap­tys­Bio is rid­ing Wall Street mo­men­tum, re­port­ing its high­est share price in al­most five years af­ter a $100 mil­lion of­fer­ing that brought Sanofi aboard. …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER